PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study shows patient-specific vaccines for metastatic melanoma may induce durable complete regression

2010-09-28
(Press-News.org) Newport Beach, CA – September 27, 2010 – Hoag Memorial Hospital Presbyterian recently announced encouraging clinical study results for patient-specific vaccine therapy to treat metastatic melanoma. The study is ongoing, but the report concludes that patient-specific vaccines can sometimes induce durable complete regression of progressing soft-tissue melanoma metastases, as demonstrated in one particular patient who participated in the trial.

The study report, entitled: "Durable Complete Response of Refractory, Progressing, Metastatic Melanoma after Treatment with a Patient-Specific Vaccine," will appear in the October issue of Cancer Biotherapy and Radiopharmaceuticals. Lead author of the report is Robert O. Dillman, MD, FACP, medical oncologist and cancer immunologist, as well as executive medical and scientific director at Hoag Cancer Institute. The study was sponsored by Hoag Hospital Foundation.

"Although we had previously shown that patient-specific vaccines can be associated with long-term disease control and survival despite previous recurrences of widespread metastatic melanoma, , , this is the first complete regression we have observed with a dendritic cell-based patient-specific vaccine therapy in patients with measurable metastatic melanoma," said Dr. Dillman.

The patient profiled in the study presented with cervical spine metastases and within the year had experienced local disease progression and, despite various therapies, metastases to the axilla, rectum, gall bladder, and multiple soft-tissue sites. She had previously received radiation therapy, combination chemotherapy, interleukin-2 plus interferon biotherapy, gamma knife radiosurgery, and undergone multiple surgical resections. At the time vaccine therapy was initiated, she had multiple new, measurable, soft-tissue metastases that were increasing in size.

The patient was treated with a vaccine consisting of autologous dendritic cells incubated with irradiated tumor cells from an autologous tumor cell line and suspended in GM-CSF, with s.c. injections once a week for three weeks and monthly for five months. There was evidence of disease regression by the completion of therapy. A few months later, a complete response was documented by radiologic scans, and subsequently reconfirmed at six-month intervals. She remains in complete remission more than 2.5 years after starting the vaccine, and more than two years after completing the vaccine, and survives more than four years after her initial presentation with bone, bowel, and lymph node metastases. This is the first time she has been in a complete remission since her initial diagnosis.

"These results are extremely encouraging for patients suffering from metastatic melanoma," said Dr. Dillman. "The promise of new therapies such as personalized cancer vaccines may help contribute to survival rates in these patients."

###

About Hoag Cancer Institute

Hoag Cancer Institute is accredited as a "Comprehensive Community Cancer Program" by the Commission on Cancer of the American College of Surgeons, and was designated as "Outstanding" following its most recent survey. The Institute provides a broad array of innovative cancer treatments as well as patient-centered education and support programs. As the highest volume provider of cancer care in Orange County, Hoag Cancer Institute manages approximately 3,000 newly diagnosed cancer patients each year, providing the latest state-of-the-art technology and treatment options. The Institute participates in a variety of clinical trials, develops patient-specific biological treatments in its cell biology laboratory, and provides a wealth of complementary care programs for patients.

About Hoag Memorial Hospital Presbyterian

Hoag is a not-for-profit regional healthcare delivery network in Orange County, Calif. that treats nearly 30,000 inpatients and 350,000 outpatients annually. Hoag consists of two acute-care hospitals, seven health centers and a network for more than 1,300 physicians, 5,000 employees and 2,000 volunteers. Hoag Hospital Newport Beach, which has served Orange County since 1952, and Hoag Hospital Irvine, which opened in 2010, are designated Magnet hospitals by the American Nurses Credentialing Center (ANCC). Hoag offers a comprehensive mix of health care services, including Centers of Excellence in cancer, heart and vascular, neurosciences, orthopedics and women's health. National Research Corporation has endorsed Hoag as Orange County's most preferred hospital for the past 14 consecutive years. And for an unprecedented 14 years, residents of Orange County have chosen Hoag as the county's best hospital in a local newspaper survey. Visit www.hoag.org.

1 Dillman RO, DePriest C, DeLeon C, et al. Patient-specific vaccines derived from autologous tumor cell lines as active specific immunotherapy: results of exploratory phase I/II trials in patients with metastatic melanoma. Cancer Biother Radiopharm 2007;22:309

2 Dillman RO, Selvan SR, Schlitz PM. Patient-specific dendritic cell vaccines for metastatic melanoma. N Engl J Med 2006;355:1179.

3 Dillman RO, Selvan SR, Schlitz PM, et al. Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific anti-tumor vaccines in patients with metastatic melanoma: Final Report. Cancer Biother Radiopharm 2009;24:311.



ELSE PRESS RELEASES FROM THIS DATE:

Diving deeper into the gene pool

2010-09-28
About ten years ago, the discovery of microRNAs ― tiny cellular molecules that regulate our genetic code ― unlocked a world of scientific possibilities, including a deeper understanding of human disease. One new analytical technology is "deep sequencing," which gives scientists the ability to discover invaluable information about human diseases at a genetic level. Now, Tel Aviv University researchers have developed the cutting-edge technology to better analyze these results. The software, called miRNAkey, was developed by Roy Ronen as part of a team of researchers ...

Elevated nitrogen and phosphorus still widespread in much of the nation's streams and groundwater

2010-09-28
Elevated concentrations of nitrogen and phosphorus, nutrients that can negatively impact aquatic ecosystems and human health, have remained the same or increased in many streams and aquifers across the Nation since the early 1990's, according to a new national study by the U.S. Geological Survey. "This USGS report provides the most comprehensive national-scale assessment to date of nitrogen and phosphorus in our streams and groundwater," said Marcia McNutt, USGS Director. "For years we have known that these same nutrients in high concentrations have resulted in 'dead ...

Tile drainage directly related to nitrate loss

Tile drainage directly related to nitrate loss
2010-09-28
URBANA – Tile drainage in the Mississippi Basin is one of the great advances of the 19th and 20th centuries, allowing highly productive agriculture in what was once land too wet to farm. In fact, installation of new tile systems continues every year, because it leads to increased crop yields. But a recent study shows that the most heavily tile-drained areas of North America are also the largest contributing source of nitrate to the Gulf of Mexico, leading to seasonal hypoxia. In the summer of 2010 this dead zone in the Gulf spanned over 7,000 square miles. Scientists ...

Urban gardeners beware: There may be lead in your soil and food

Urban gardeners beware: There may be lead in your soil and food
2010-09-28
INDIANAPOLIS – Not since victory gardens helped World War II era Americans on the home front survive food shortages have urban gardens been as necessary and popular as they are today. With more food production in cities, the safety of the produce grown there becomes increasingly important. As city dwellers across the country are harvesting fruits and vegetables for family consumption and planning ahead for the next planting season, geochemist Gabriel Filippelli, Ph.D., professor of earth sciences at the School of Science at Indiana University-Purdue University Indianapolis, ...

A shot to the heart: Nanoneedle delivers quantum dots to cell nucleus

A shot to the heart: Nanoneedle delivers quantum dots to cell nucleus
2010-09-28
CHAMPAIGN, Ill. — Getting an inside look at the center of a cell can be as easy as a needle prick, thanks to University of Illinois researchers who have developed a tiny needle to deliver a shot right to a cell's nucleus. Understanding the processes inside the nucleus of a cell, which houses DNA and is the site for transcribing genes, could lead to greater comprehension of genetics and the factors that regulate expression. Scientists have used proteins or dyes to track activity in the nucleus, but those can be large and tend to be sensitive to light, making them hard ...

Study: Electric cars hold greater promise for reducing emissions and lowering US oil imports

2010-09-28
Electric cars hold greater promise for reducing emissions and lowering U.S. oil imports than a national renewable portfolio standard, according to research conducted by Rice University's Baker Institute for Public Policy. This assessment is among several contained in a new major policy study the Baker Institute Energy Forum will release at a Sept. 27-28 conference titled "Energy Market Consequences of an Emerging U.S. Carbon Management Policy." The study comprises several academic working papers on a variety of topics, such as carbon pricing, the wind industry, global ...

How injured nerves grow themselves back

2010-09-28
Unlike nerves of the spinal cord, the peripheral nerves that connect our limbs and organs to the central nervous system have an astonishing ability to regenerate themselves after injury. Now, a new report in the October 1st issue of Cell, a Cell Press publication, offers new insight into how that healing process works. "We know a lot about how various cell types differentiate during development, but after a serious injury like an amputation, nerves must re-grow," said Allison Lloyd of University College London. "They need a new mechanism to do that because the developmental ...

Rain or shine, Sandia researchers find new ways to forecast large photovoltaic power plant output

2010-09-28
ALBUQUERQUE, N.M. – Sandia National Laboratories researchers have developed a new system to monitor how clouds affect large-scale solar photovoltaic (PV) power plants. By observing cloud shape, size and movement, the system provides a way for utility companies to predict and prepare for fluctuations in power output due to changes in weather. The resulting models will provide utility companies with valuable data to assess potential power plant locations, ramp rates and power output. Sandia researchers' work is currently focused at the 1.2-megawatt La Ola Solar Farm on ...

New guideline finds no evidence for a popular back procedure

2010-09-28
Rosemont, Ill. – As a patient safety best practice and endorsement of evidence-based medicine, the American Academy of Orthopaedic Surgeons (AAOS) Board of Directors approved and released a clinical practice guideline, which found a strong recommendation against a popular procedure called vertebroplasty as a way to treat fractures in the spine. Clinical practice guidelines are one avenue the Academy uses to ensure that patients receive high quality care. Vertebroplasty is a surgical procedure developed to reduce or eliminate the pain associated with compression fractures ...

Sugary sports drinks mistakenly associated with being healthy, say UTHealth researchers

2010-09-28
HOUSTON (Sept. 27, 2010) – Children who practice healthy lifestyle habits such as eating fruits and vegetables and engaging in physical activity may be negatively impacting their health because they tend to consume large amounts of flavored and sports beverages containing sugar, according to research at The Michael & Susan Dell Center for Healthy Living at The University of Texas Health Science Center at Houston (UTHealth). "Children and parents associate these drinks with a healthy lifestyle despite their increased amount of sugar and lack of nutritional value," said ...

LAST 30 PRESS RELEASES:

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

When getting a job makes you go hungry

Good vibrations could revolutionize assisted reproductive technology

[Press-News.org] Study shows patient-specific vaccines for metastatic melanoma may induce durable complete regression